Incyte to raise funds through private placement

NewsGuard 100/100 Score

Incyte Corporation (Nasdaq: INCY) today announced the pricing of its offering of $350 million aggregate principal amount of 4.75% Convertible Senior Notes due 2015 in a private placement to qualified institutional buyers pursuant to exemptions from the registration requirements of the Securities Act of 1933. The size of the offering was increased from the originally announced $250 million aggregate principal amount. The offering is expected to close on September 30, 2009, subject to customary closing conditions. Incyte has granted the initial purchasers of the notes a 30-day option to purchase up to an additional $50 million aggregate principal amount of the notes.

The notes will be convertible into shares of Incyte common stock, or shares of preferred stock in lieu of common stock, at an initial conversion rate of 113.9601 shares of common stock per $1,000 principal amount of notes (subject to adjustment in certain circumstances), which represents an initial conversion price of approximately $8.78 per share.

Incyte intends to use the net proceeds from the offering to repurchase or otherwise retire outstanding debt, including its existing 3½% Convertible Senior Notes due 2011 and 3½% Convertible Subordinated Notes due 2011, through open market transactions, negotiated transactions or otherwise, including potential repurchases from its affiliates, and, to the extent not used to repurchase or otherwise retire outstanding debt, for general corporate purposes. Incyte also intends to use a portion of the net proceeds to fund the escrow account to be used for the first six scheduled semi-annual interest payments on the notes.

Posted in:

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.